Product
Recombinant von Willebrand factor
1 clinical trial
1 indication
Indication
Von Willebrand DiseaseClinical trial
Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize StudyStatus: Terminated, Estimated PCD: 2022-04-30